- Methodology article
- Open Access

# Comparative analysis of methods for detecting interacting loci

- Li Chen
^{1}, - Guoqiang Yu
^{1}, - Carl D Langefeld
^{2}, - David J Miller
^{3}, - Richard T Guy
^{2}, - Jayaram Raghuram
^{3}, - Xiguo Yuan
^{1}, - David M Herrington
^{4}and - Yue Wang
^{1}Email author

**12**:344

https://doi.org/10.1186/1471-2164-12-344

© Chen et al; licensee BioMed Central Ltd. 2011

**Received:**25 February 2011**Accepted:**5 July 2011**Published:**5 July 2011

## Abstract

### Background

Interactions among genetic loci are believed to play an important role in disease risk. While many methods have been proposed for detecting such interactions, their relative performance remains largely unclear, mainly because different data sources, detection performance criteria, and experimental protocols were used in the papers introducing these methods and in subsequent studies. Moreover, there have been very few studies strictly focused on comparison of existing methods. Given the importance of detecting gene-gene and gene-environment interactions, a rigorous, comprehensive comparison of performance and limitations of available interaction detection methods is warranted.

### Results

We report a comparison of eight representative methods, of which seven were specifically designed to detect interactions among single nucleotide polymorphisms (SNPs), with the last a popular main-effect testing method used as a baseline for performance evaluation. The selected methods, multifactor dimensionality reduction (MDR), full interaction model (FIM), information gain (IG), Bayesian epistasis association mapping (BEAM), SNP harvester (SH), maximum entropy conditional probability modeling (MECPM), logistic regression with an interaction term (LRIT), and logistic regression (LR) were compared on a large number of simulated data sets, each, consistent with complex disease models, embedding *multiple* sets of interacting SNPs, under different interaction models. The assessment criteria included several relevant detection power measures, family-wise type I error rate, and computational complexity. There are several important results from this study. First, while some SNPs in interactions with strong effects are successfully detected, most of the methods miss many interacting SNPs at an acceptable rate of false positives. In this study, the best-performing method was MECPM. Second, the statistical significance assessment criteria, used by some of the methods to control the type I error rate, are quite conservative, thereby limiting their power and making it difficult to fairly compare them. Third, as expected, power varies for different models and as a function of penetrance, minor allele frequency, linkage disequilibrium and marginal effects. Fourth, the analytical relationships between power and these factors are derived, aiding in the interpretation of the study results. Fifth, for these methods the magnitude of the main effect influences the power of the tests. Sixth, most methods can detect some ground-truth SNPs but have modest power to detect the whole set of interacting SNPs.

### Conclusion

This comparison study provides new insights into the strengths and limitations of current methods for detecting interacting loci. This study, along with freely available simulation tools we provide, should help support development of improved methods. The simulation tools are available at: http://code.google.com/p/simulation-tool-bmc-ms9169818735220977/downloads/list.

## Keywords

- Minor Allele Frequency
- Information Gain
- Multifactor Dimensionality Reduction
- Detection Power
- False Positive Interaction

## Background

Genome-wide association studies (GWAS) have been widely applied recently to identify SNPs associated with common human diseases [1–9], including cardiovascular diseases [6, 10–13], diabetes [6, 14–18], lupus [19–21], autoimmune diseases [22], autism [23], and cancer [24–27]. However, with few exceptions [13, 15, 17, 24], the discovered genetic variants with significant main effects account for only a small fraction of clinically important phenotypic variations for many traits [5, 28]. While there are multiple causes for missing some well-known genetic risk factors or disease heritability (including e.g., rare variants not genotyped in a GWAS study), a frequently cited reason is that most common diseases have complex mechanisms, involving multi-locus gene-gene and gene-environment interactions [5, 28–31]. For detecting interacting loci in high dimensional GWAS data with sufficient power and computational feasibility, some pioneering work, with promising results, has been reported, encompassing: i) real GWAS study papers, as cited above; ii) interaction detection methodology [32–44]; iii) theoretical papers that characterize the principle problem (interaction detection) and its challenges [30, 45–47]; iv) review and methods comparison papers [29, 31, 47–51].

### Novel Methods for Detecting Interacting SNPs

A variety of SNP interaction detection methods have been recently proposed. In particular, multifactor dimensionality reduction (MDR) [33] measures the association between SNPs and disease risk using prediction accuracy of selected multifactor models. Full interaction model (FIM) [41] applies logistic regression, 3 using ^{
d
} -1 binary variables constructed based on a *d*-SNP subset. Information gain (IG) [34, 52] measures mutual information to assess multi-locus joint effects. Bayesian epistasis association mapping (BEAM) [32] treats the disease-associated markers and their interactions via a Bayesian partitioning model and computes, via Markov chain Monte Carlo (MCMC), the posterior probability that each SNP set is associated with the disease. SNP harvester (SH) [39] proposes a heuristic search to reduce computational complexity and detect SNP interactions with weak marginal effects. Random forest (RF) [44] is an ensemble classifier consisting of many decision trees, each tree using only a subset of the available features for class decision making. Thus, the detected features (SNPs) are the ones most frequently used by trees in the ensemble. Logic regression (LOR) [36] identifies interactions as Boolean (logical) combinations of SNPs. In [42], an extension of logic regression was also proposed to identify SNP interactions explanatory for the disease status, with two measures devised for quantifying the importance of these interactions for the accuracy of disease prediction. Treating SNPs and their interaction terms as predictors, penalized logistic regression (PLR) [37] maximizes the model log-likelihood subject to an L2-norm constraint on the coefficients. Related to FIM and PLR, adaptive group lasso (AGL) [43] adds all possible interaction effects at first and second order to a group lasso model, with L1-norm penalized logistic regression used to identify a sparse set of marginal and interaction terms. Maximum entropy conditional probability modeling (MECPM) [40], applying a novel, deterministic model structure search, builds multiple, variable-order interactions into a phenotype-posterior model, and is coupled with the Bayesian Information Criterion (BIC) to estimate the number of interaction models present. Logistic regression with an interaction term (LRIT) has been widely applied to detect interactions [35]. It treats the multiplicative term between SNPs, along with individual SNP terms, as predictors in the logistic regression model.

### Evaluation of Methods to Detect Interacting SNPs

Despite strong current interest in this area and a number of recent review articles [29, 31, 47–51], no commonly accepted performance standards for evaluating methods to detect multi-locus interactions have been established. For example, one might choose to evaluate power to detect individual SNPs involved in interactions, or power to precisely detect whole (multi-SNP) interactions. Moreover, the relationship between the power to detect interacting loci and the factors on which it depends (penetrance, minor allele frequency (MAF), main effects, and LD), while considered in some previous studies [32, 41, 43, 45, 53], has not been fully investigated, either experimentally or analytically. Most importantly, although some assessment and performance comparison was undertaken both in the original papers proposing new methods [32–34, 39, 41, 43] and in the comparison papers [49, 50], it is difficult to draw definitive conclusions about the absolute and relative performance of these methods from this body of studies due to the following: (1) each study was based on a different simulation data set and a different set of experimental protocols (including the detection power definition used, the sample size, the number of evaluated SNPs, and the computational allowance of methods). While use of different data sets and protocols may be well-warranted, as it may allow a study to focus on unique scenarios/application contexts not considered previously, it also makes it difficult to compare the performance of methods, excepting those head-to-head evaluated in the same study. Some methods were found to perform quite favorably in one study but poorly in others. For example, MDR [33] performed well in the original simulation study and the comparison paper [50], but poorly in subsequent studies [32, 40, 43]; (2) often, only simple cases were tested, which may not reflect the realistic application of a method. For example, a common practice is to include only a *single* interaction model in the data [32–34, 39, 41, 50], whereas common diseases are usually complex, with multiple genetic causes [28], suggesting that *multiple* interaction models should be present. Our previous papers [40, 54] considered multiple interaction models, but an insufficient number of data set replications to draw definitive conclusions on relative performance of methods [50]. also evaluated multiple interaction models, but only compared three methods, evaluated only one interaction power definition, and did not comprehensively evaluate the effects of penetrance, MAF, main effects, and linkage disequilibrium (LD) on power; (3) only limited interaction patterns were considered, e.g. 2-way interactions but no *higher-order* interactions in [43, 49]. This is an important limitation, especially considering that data sets with 1000 or fewer SNPs were evaluated in these studies - in such cases, exhaustive evaluation of candidate pairwise interactions is computationally feasible, whereas *heuristic* search, which will affect detection power in practice, is necessitated if either higher order interactions or much larger SNP sets are considered. Thus, to more realistically assess detection power, either higher order interactions and/or more SNPs should be considered; (4) Perhaps most critically, methods providing P-value assessments [32, 39, 41] evaluated power for a given significance threshold, but did not rigorously evaluate the *accuracy* of the P-value assessment, i.e. whether the Bonferroni-corrected P-value *truly* reflects the family-wise type I error rate [55]. This evaluation is of great importance for methods that use asymptotic statistics [32, 39, 41], since it reveals whether or not the asymptotic P-value is a reliable detection criterion. Specifically, the P-value could be too liberal (in which case, more family-wise errors than expected will occur in practice and the estimated detection power is too optimistic) or too conservative (in which case the detection power estimate is too pessimistic). By not performing such assessment, it is unclear even whether use of P-values is providing a fair comparison of detection power between methods (*i.e*., for the same family-wise error rate) in [32, 39, 41]. We further note that although there were efforts to measure the type I error rate in [32, 43, 50], the evaluations were not based on the commonly used *family-wise error rate*, but rather on another definition of type 1 error [32] that does not directly reflect the Bonferroni-corrected P-value; (5) In most past studies [32–34, 39, 41, 43, 50], only a single definition of an interaction detection event (and, thus, a single measure of detection power) was used. However, this does not capture the full range of relevant detection events for some applications of GWAS. In particular, in some works an exact joint detection event is defined, *i.e*. detection is successful only if all SNPs involved in the interaction (and *only* these SNPs) are jointly detected [43, 50]. This is a stringent definition that gives no credit to a method that detects a subset of the interacting SNPs (*e.g*. 3 of the SNPs in a 5-way interaction), even though such partial detection is clearly helpful if *e.g*. one is seeking to identify a gene pathway, or if the remaining SNPs in the interaction can be subsequently detected by applying more sensitive (and computationally heavy) methods. Exact detection is especially stringent when there are *multiple* interactions present, with the disease risk effectively divided between the multiple models. Finally, we note that individual methods have their own inductive biases and, thus, may perform better under different detection criteria - one method may find more ground-truth SNPs, while another may be more successful at finding whole interactions. Use of multiple power definitions can reveal these differences between methods; (6) Most of the proposed methods (*e.g*. MDR, FIM, BEAM, MECPM, SH) are designed to detect both main effects and interaction effects, while to date they have only been evaluated on data sets containing interactions. It is thus also meaningful to measure how effective they are at detecting SNPs with only main effects, and how many false positive *interactions* they detect involving main effect SNPs.

Finally, we note that there are very few true (strict) *comparison* papers - most studies have focused on developing new methods, with experimental evaluation not the central paper focus. Two exceptions are [50] and [49]. However, they both embedded only a single interaction model in the data and considered data sets with only 100 SNPs; Moreover, [50] evaluated only 2-way and 3-way interaction detection, while [49] evaluated only two-way interaction detection.

The aforementioned limitations of previous studies are not surprising because of the following challenges associated with comparison studies: (1) it is impractical to evaluate methods on all of the (numerous possible) interaction models; (2) multiple aforementioned factors (MAF, penetrance, LD) jointly decide interaction effects, which thus entails extensive study design, experimentation, and computational efforts; (3) many replicated data sets are required to accurately estimate power and family-wise type I error rate, further increasing computational burden; (4) computational costs of some methods are inherently high; thus a thorough evaluation of these methods is a difficult hurdle; and (5) fair evaluation criteria are not easily designed because distinct methods have different inductive biases and produce different forms of output (e.g., some give P-value assessments while others only provide SNP rankings); (6) there is no consensus definition of power when seeking to identify *multiple sets* of predictors that are jointly associated with outcomes of interest.

Addressing the above challenges, a ground-truth based comparative study is reported in this paper. The goals are three-fold: (1) to describe and make publicly available simulation tools for evaluating performance of any technique designed to detect interactions among genetic variants in case-control studies; (2) to use these tools to compare performance of eight popular SNP detection methods; (3) to develop analytical relationships between power to detect interacting SNPs and the factors on which it depends (penetrance, MAF, main effects, LD), which support and help explain the experimental results.

Our simulation tools allow users to vary the parameters that impact performance, including interaction pattern, MAF, penetrance (which together determine the strength of the association) and the sporadic disease rate, while maintaining the normally occurring linkage disequilibrium structure. Also, the simulation tools allow users to embed multiple interaction models within each data set. These tools can be used to produce any number of test sets composed of user specified numbers of subjects and SNPs.

*e.g*. P-value based) significance threshold is used as the criterion for detecting interacting SNPs.

In particular, foreshadowing our Step 1 results, we will find that *most* methods (except LR) in this study that produce P-values in fact produce conservative ones, with the degree of conservativeness method-dependent. Thus, using the same P-value threshold for all methods will not ensure the methods are being fairly compared, at a common family-wise error rate. Both for this reason, and because some of the methods do not even produce P-values, in Step 2 we evaluate detection power as a function of the number of top-ranked SNPs, rather than for a specified P-value threshold. Accordingly, note the logical structure in Figure 1, with the Step 1 results helping us to determine how to evaluate detection power in Step 2.

As aforementioned, Step 2 (with a variety of ground-truth interaction models present) investigates power. We formulate a more challenging, yet more realistic situation than most previous studies by including *multiple* ground-truth interaction models in each simulated data set. These simulations are motivated in part by our experience with complex genetic diseases such as autoimmune diseases, diabetes and end-stage renal disease [18, 19, 56, 57]. In total, ninety different interaction models are investigated in this study, jointly determined by 5 underlying interaction types and 3 parameters, controlling penetrance, MAF, and LD. Step 3 investigates the power to detect main effect SNPs, *i.e*. we investigate how the methods (many of which are designed to detect both interactions and main effect SNPs) perform when only main effects are present in the data.

The main contributions and novelty of our comparison study are: (1) comprehensive comparison of state-of-the-art techniques on realistic simulated data sets, each of which includes multiple interaction models; (2) new proposed power criteria, well-matched to distinct GWAS applications (*e.g*., detection of "at least one SNP in an interaction"); (3) evaluation of the *accuracy* of (P-value based) significance assessments made by the detection methods; (4) investigation of detection of models with variable order interactions (up to 5th order) in SNP data sets; (5) new analytical results on the relationship between interaction parameters and statistical power; (6) investigation of the flexibility of interaction-detection methods, *i.e*. whether (and with what accuracy) they can detect both interactions and main effects; (7) discoveries concerning relative performance of methods (*e.g*., comparative evaluation of the promising recent method, MECPM). Since we are presenting a diversity of results, both experimental and analytical, to assist the reader in navigating our work, Figure 1 gives a graphical summary of our experimental steps, the results produced there from, and the connections between the different results, both experimental and analytical.

## Results

### Experimental Design and Protocol

We selected eight representative methods for evaluation, based on their reported effectiveness and computational efficiency. Seven of them (MDR, FIM, IG, BEAM, SH, MECPM and LRIT) are designed to detect interacting loci, with the remaining one based on the widely-used logistic regression model (LR). LR, using only main effect terms, serves as a baseline method to compare against all the interaction-detection methods, i.e., to see whether they give any advantage over pure "main effect" methods when the goal is simply to detect the subset of SNPs that either individually, or via interactions, are predictive of the phenotype. The description of the eight methods is given in the "Methods" part.

#### Simulation Data Sets

*S*, which accounts for the missing heritability and other disease-related factors. Let

*P*

_{ r }(

*d*

_{ i }),

*r*= 1,2,...,

*R*be the disease probability generated by

*R*interaction models for the

*ith*subject. Assuming all disease factors act independently, disease risk of this subject is then

The simulation data sets have different ground truth interaction models *P*_{
r
} (*d*_{
i
} ), *r* = 1,2,...*R* and the sporadic disease rate *S* for different steps. For Step 1, we did not embed any ground truth SNPs in the data sets; for Step 2, we embedded five interaction models in each data set; and for Step 3, we embedded five main-effect-only SNPs in each data set. In all three steps, we adjusted the sporadic rate *S* so that each data set has approximately 1,000 cases and 1,000 controls, the typical situation (balanced cases and controls) in GWAS studies, e.g. in Step 1, *S* = 0.5. The ground truth interaction models in Step 2 and the ground truth main-effect-only SNPs will be described later.

The simulation approach used in this comparison study is the same as that used in [40]. Our simulation approach has one commonality with, but two main differences from the simulation approaches used in the previous methods and comparison study papers evaluating MDR, IG, FIM, SH, and BEAM [32–34, 39, 41, 50]. Both in these papers and in our current study, all SNPs are consistent with Hardy-Weinberg Equilibrium. However, in these previous papers, the simulated data were purely synthetic, generated according to user-specified allele frequencies [29–31, 36, 38, 47]. By contrast, our simulated data is obtained by resampling from real genome scan data and is thus more realistic, preserving the allele frequencies and LD structure manifested by the original genome scan data. Another resampling simulation method was proposed in [58, 59], but this approach has not been used for evaluating the MDR, IG, FIM, SH, and BEAM methods. Another important distinction between our simulation method and other simulation methods lies in the phenotype generation. In our simulation, multiple interactions simultaneously exist in each data set (which is reasonable considering complex disease mechanisms) and jointly decide the phenotype; by contrast, other simulation methods usually embed only one SNP interaction (i.e., single interaction model) in each data set [32–34, 39, 41, 50]. Also, we consider interactions with interaction order from 2 to 5, while most other simulations [33, 34, 39, 41, 50] only consider interactions with interaction order up to 3.

As mentioned previously, our simulation study consists of three main experimental steps, which we next more fully describe.

#### Step 1: assess family-wise type I error rate

An accurate family-wise type I error rate is crucial for methods that select candidate SNPs based on their P-values and for reliably comparing methods. If the family-wise type I error rate is either conservative or liberal, the P-value loses its intended meaning and does not reflect the actual false positive rate. That is, we will not be able to control how many false positives are detected by setting a (*e.g*. P-value based) threshold. For example, a method with a lower family-wise type I error rate than expected (based on the estimated P-value) sets a threshold that overestimates the empirical false positive rate; thus, fewer false positives (than the target) will be selected, likely also leading to fewer true associations being identified.

BEAM, SH and FIM detect significant SNPs based on P-values calculated from asymptotic distributions and heuristic searches. Thus, based on the preceding discussion, evaluating the accuracy of their P-value assessments is not only of theoretical importance (how well their proposed asymptotic distributions approximate the real distribution), but also of great practical necessity in applying these methods.

To evaluate the accuracy of P-value assessment, we replicated 1,000 data sets by repeatedly randomly selecting 1,000 null SNPs from the SNP pool, i.e. to easily assess family-wise type I error rate, no ground-truth SNPs were embedded in these data sets.

#### Step 2: assess power

In step 2, each data set has *N* SNPs, with 15 ground-truth SNPs and *N*-15 null SNPs, selected via the procedure described in the "*Simulation Data Sets*" subsection. *N* is chosen to be either 1000 or 10,000 for different experiments. There are several points to make regarding the number of SNPs we consider. First, assuming approximately 1000~10,000 SNPs is realistic for candidate gene and biological pathway studies where interaction detection is needed. Second, considering GWAS studies, a 0.15%~1.5% percentage of ground-truth SNPs realistically models the output of first stage SNP screening/filtering (which greatly reduces the number of candidate SNPs) in the widely-applied 2-stage GWAS detection process. Finally, the 1000~10,000 SNPs considered here is much larger than the 100 SNPs in the previous comparison study [49, 50] and comparable to that considered in several other recent papers.

The 15 ground-truth SNPs each participate in one of 5 ground-truth SNP interactions, which contribute independently to the disease, as described by equation (1). There are three standard factors that determine interactions: penetrance, MAF and LD [3, 7]. Penetrance is the proportion of individuals with a specific genotype who manifest the phenotype. For example, if all individuals with a specific disease genotype show the disease phenotype, then the penetrance value is 1 and the genotype is said to be "completely penetrant"; otherwise, it is "incompletely penetrant" [3]. LD is the non-random association of alleles of different linked polymorphisms in a population [7]. MAF is the frequency of the least common allele of a polymorphic locus. It has a value that lies between 0 and 0.5, and can vary between populations [7]. The 5 ground-truth SNP interactions are jointly determined by 5 basic model types and 3 (discrete-valued) parameters, controlling the MAF, penetrance, and LD, which will be specified later. Based on the choices for these 3 parameters, there are 3 × 3 × 2 = 18 possible parameter configurations (so the aforementioned ninety models are generated by the 5 basic model types, each with 18 different parameter settings). Each configuration is applied simultaneously to the 5 basic models, thus yielding 5 fully specified interaction models for a given data set. With some allowable randomness in the 5 new interaction models, we generated 100 replication data sets for each configuration with *N =* 1000, and 10 replication data sets for one typical configuration with *N =* 10,000; thus we have in total 18 × 100+10 = 1,810 data sets in step 2, involving 18 × 5 = 90 interaction models.

**The 5 basic models** vary in interaction order, genetic models (dominant, recessive, or additive), incomplete/complete penetrance, MAF, and marginal effects. To indicate the strength of interaction effects and main effects for each basic model, we calculated the odds ratio by dichotomizing the genotypes of each interaction into a group with the lowest penetrance value (usually with "0" penetrance) and another group with higher penetrance values (the specific calculation can be found in section S4 of the Additional file 1).

The 5 basic models are defined by the penetrance tables and MAFs below. The penetrance function is the probability of disease given the individual's genotype. Thus, the penetrance tables show the probability of developing disease given the genotypes [3, 60], with each table entry being the disease probability conditional on the specific single or multi-locus genotypes. The interaction models are motivated by our experience studying complex genetic traits where there are multiple loci contributing to disease risk. Specifically, the simulation study is motivated by our experience in autoimmune diseases, diabetes and renal diseases where there are some larger effects (e.g., human leukocyte antigen region in autoimmune diseases such as systemic lupus erythematosus, neonatal lupus, and juvenile arthritis [19]; and gene APOL1 in end-stage renal disease in African Americans [18]), and multiple modest to smaller effects with 1.1 < odds ratios < 1.3. To date, there are few robustly established (i.e., with convincing discovery evidence on multiple replications in independent cohorts) gene-gene interactions in the human disease literature. Thus, we attempted to be consistent with the complex genetic disease paradigm and assumed multiple loci, several interacting, contribute to the risk of disease. We examined combinations of SNPs in the lupus genome-wide scan (Harley et al, 2008) to estimate some examples of potential two-locus interactions as well as constructed other higher-order interactions consistent with traditional interpretations of Mendelian inheritance (i.e., dominant, additive or recessive genetic model) but spanning multiple loci. Some interactions are based on a two-locus, common allele with a low penetrance model as might be hypothesized in diabetes from the "thrifty gene hypothesis" [56] and other multi-locus models are modest penetrance models for the low frequency alleles. Additional motivation comes from studies of epistasis [57]. The five locus interaction is a conjectural one that should challenge these analytic methods.

**Basic model 1**-.two-locus interaction under a dominant model for the major allele. The model is for two very common but low penetrant alleles. The MAFs at these two loci are both 0.25. This model is expected to generate 62 cases per 1000 subjects. The odds ratio is 1.16 for the joint interaction effect between

*A*and

*B*, and 1.15 for main effects of both

*A*and

*B*. This model simulates the situation of common disease where the major allele is disease-related but with weak interaction effects. "M1" denotes model 1. denotes the homozygous major allele genotype of SNP A; denotes the heterozygous genotype of SNP A; denotes the homozygous minor allele genotype of SNP A; likewise for the notations in the other basic models.

**Basic model 2**- two-locus interaction for common alleles under a dominant genetic model at each locus. The minor allele frequencies are 0.20 for locus

*A*and 0.30 for locus

*B*. This model is expected to generate 102 cases per 1000 subjects. The odds ratio is 3.79 for the joint interaction effect between

*A*and

*B*, 1.89 for the main effect of

*A*and 1.56 for the main effect of

*B*. This model simulates the situation that the minor allele is disease-related, and both interaction effects and main effects are strong.

**Basic model 3**- three-locus interaction, common alleles, incomplete penetrance. The MAFs at the three loci are 0.40 for

*A*, 0.25 for

*B*, and 0.25 for

*C*. This model is expected to generate 46 cases per 1000 subjects. The odds ratio is 2.28 for the joint interaction effect among

*A, B*and

*C*, 1.16 for the main effect of

*A*, 1.25 for the main effect of

*B*, and 1.25 for the main effect of

*C*.

**Basic model 4**- three-locus interaction among common alleles. The minor allele frequencies are 0.25 for

*A*, 0.20 for

*B*, and 0.20 for

*C*. This model is expected to generate 26 cases per 1000 subjects. The odds ratio is 5.79 for the joint interaction effect among

*A, B*and

*C*, 2.45 for the main effect of

*A*, 1.06 for the main effect of

*B*, and 1.06 for the main effect of

*C*. This model has strong interaction effects and a strong main effect at

*A*, but weak main effects at

*B*and

*C*. Two-SNP subsets of the three-locus interaction, {

*A, B*} and {

*A, C*}, also have strong effects.

**Basic model 5**- five-locus interaction among common alleles. It assumes a MAF of 0.30 at each locus and has a penetrance value of 0.63 if the minor allele is present at each locus; and 0 otherwise. In equation form, the penetrance function is:

where *D* means the subject gets disease. This model is expected to generate 22 cases per 1000 subjects. The odds ratio is 4.48 for the joint interaction effect among the five loci, and 1.09 for the main effect at all five loci. This model simulates the situation of significant high-order interaction effects but weak main effects.

**Three parameters**are used to assess the robustness of the various methods to variations in penetrance, MAF, and LD, because i) as aforementioned, penetrance, MAF, and LD jointly define the disease model, and thus decide the disease status; ii) it is of interests, in the field of SNP interaction detection, to explore how detection power varies with these parameters [32, 34, 41, 43, 50]; iii) we have derived the analytical relationships between interaction effects and these parameters in the Additional file 1, so a simulation study using these parameters provides us the opportunity to validate the analytical relationships in an empirical way. For each basic model, we control its penetrance by multiplying every value in the penetrance table by the penetrance factor (multiplier)

*θ*∈{1,1.3,1.4} (the larger

*θ*is, the larger disease risk there will be); we discount the MAF by multiplying the MAF of each SNP by a MAF factor

*β*∈{1,0.9,0.7} (the larger

*β*is, the larger frequency the minor allele will have); and to control the LD level, we replace each ground-truth SNP by an "LD SNP", which has a certain correlation coefficient

*l*∈{0.8,

*null*} with the ground-truth SNP (

*l*=

*null*means we do not replace the ground-truth SNP). The "LD SNP" simulates the realistic case where the ground-truth SNP is not directly genotyped; in this case we may detect a SNP in LD with the ground-truth SNP. For example, for basic model 2, under parameters

*θ, β, l*, the MAFs are 0.2 *

*β*for locus

*A*and 0.3 *

*β*for locus

*B, θ*determines a new penetrance function shown below, and if

*l*= 0.8, we replace

*A*/

*B*by a SNP correlated to

*A*/

*B*with correlation coefficient 0.8.

The theoretical, analytical relationship among penetrance, MAF, and statistical significance of an interaction model is investigated in the Additional file 1, with these results also summarized in the "Experimental Results" section.

#### Step 3: assess the power to detect SNPs with only main effects

Most of the interaction-detection methods are designed to find either interactions or main effects (*e.g*. MDR, FIM, BEAM, MECPM and SH). Thus, it is meaningful to see how these methods fare in detecting main effects and also whether they detect false positive interactions (which may involve either null and/or main effect SNPs) when there are *only* main effects present.

In Step 3, we simulated 100 replication data sets, following a similar approach

as in Step 2. Each data set includes five main-effect ground truth SNPs and 995 null SNPs. The penetrances and MAFs for the five ground truth SNPs are:

Although SNP 1 and SNP 5 have relatively weaker effects, we still included them because (1) they also affect many subjects' disease status, since a large proportion of subjects carry the disease genotype of SNP1 and SNP 5 (which simulates common-disease markers); (2) our experimental results will show that these weak-effect SNPs differentiate the performance of the methods.

Note that we configured the methods to detect both main effects *and* interaction effects since, in practice, it will not be known whether interactions are present or not.

### Design of Performance Measures

The performance of the methods is evaluated by the accuracy of P-value assessment, various definitions of power, reproducibility, and computational complexity.

#### A. Family-wise type I error rate (the accuracy of P-value assessment)

There are 1,000 SNPs in each data set. Thus there are multiple comparison effects, and the P-values obtained by the methods are accordingly adjusted by Bonferroni correction. In this way, the accuracy of P-value assessment is represented by the family-wise type I error rate: an error event occurs on a data set with no ground truth SNPs if there are *any* (necessarily false) positive detections. Since SH, MDR and FIM use Bonferroni correction, we measure the accuracy of their P-value assessments by how well the significance threshold (P-value) agrees with the family-wise type I error rate.

#### B. Various power definitions and the ROC curve

Power can be defined in several ways, depending on what we desire to measure. We next give several power definitions experimentally evaluated in the sequel.

##### Power to progressively detect interactions (Power definition 1)

*the frequency with which a model's ground-truth SNPs are ranked within the top K positions*. Several comments are in order here. First, it is important to note that the significance threshold is not being applied to define power because (1) the methods' P-value assessments are, as noted earlier, conservative (as shown in the sequel), and (2) not all methods provides significance assessments (

*e.g*. IG and MECPM). Second, in our experiments, the ranking of a SNP is decided by the strength of effect of the most significant interaction that includes this SNP. Third, note that each data set contains

*multiple*interaction models, with the detection power measured separately for each model. In measuring the power to detect SNPs in a given interaction amongst the top

*K*SNPs, we are only interested in whether the ground-truth SNPs in the interaction are ranked higher than null SNPs, not whether they are ranked higher than ground-truth SNPs from other interactions that are present. Accordingly, when measuring the power to detect SNPs in a given interaction, we do not rank ground-truth SNPs from other interactions, but only rank SNPs from the given interaction and all null SNPs. For an

*M*-way interaction, let {

*x*

_{ K }(

*i*),

*i*= 1,2,...,100} be the number of its ground-truth SNPs reported within the top

*K*SNPs over the 100 replicated data sets. The power for this interaction model is then given by:

We can also define power over the *entire* ground-truth SNP set by setting *M* = 15 and considering all ground-truth SNPs in the ranking.

##### Power to precisely detect interactions (power definition 2: exact interaction power)

*for an M-way ground-truth interaction, how likely it is detected amongst the top K M-way candidates produced by a method*. This power definition evaluates the sensitivity to detect the interaction

*as a whole*, rather than as individual SNPs. Again, similar to power

*definition 1*, in evaluating the top

*K M*-way candidates, we only consider

*M*-way combinations that include ground-truth SNPs from the interaction of interest and null SNPs,

*i.e*. we exclude

*M*-way SNP combinations involving any SNPs that participate in other ground truth interactions. Mathematically, for an

*M*-way interaction {

*s*

_{1},...,

*s*

_{ M }}, in the

*ith*data set, if {

*s*

_{1},...,

*s*

_{ M }} is detected within the top

*K M*-way candidates,

*x*

_{2, i}(

*K*) = 1; otherwise,

*x*

_{2, i}(

*K*) = 0. Power

*definition 2*is then given by:

##### Power to detect at least 1 SNP in the ground-truth interaction (power definition 3: partial interaction power)

*subset*of the interacting SNPs may have strong association to disease risk. Detecting an interaction subset should be acceptable since this gives a good "clue" to help further identify the complete interaction. We thus give power

*definition 3*as follows: for an

*M*-way interaction model {

*s*

_{1},...,

*s*

_{ M }}, if any SNP from {

*s*

_{1},...,

*s*

_{ M }} is within the top

*K*SNPs reported by the methods (excluding other ground-truth SNPs that do not participate in this interaction model),

*x*

_{3,i}(

*K*) = 1; otherwise,

*x*

_{3,i}(

*K*) = 0. Power

*definition 3*is then given by:

##### Power to detect individual SNPs (power definition 4: single SNP power)

*e.g*., differences in MAF, asymmetric penetrance table and thus different main effects, which may largely affect their potential for being detected. So it is also necessary to see how well individual ground-truth SNPs with different MAFs, penetrances, and main effects, are detected by the 5 methods. Accordingly, we give power

*definition 4*as follows. For a ground-truth SNP

*s*

_{ j }

*, j*= 1,2,...,15, if

*s*

_{ j }is within the top

*K*SNPs reported (excluding the other ground-truth SNPs),

*x*

_{ i }(

*K*) = 1; otherwise,

*x*

_{ i }(

*K*) = 0. The single SNP power for

*s*

_{ j }is then given by:

##### ROC curve

We also evaluate the methods via the ROC curve, which shows how many ground-truth SNPs are detected for a given false positive SNP count.

#### C. Reproducibility

#### D. Computational complexity

Computational complexity was measured by the execution time and memory occupancy of the methods for the same platform.

### Experimental Results

In Step 1, we evaluated the three methods with asymptotic statistics (FIM, BEAM and SH). In Step 2, we evaluated all eight methods (as described in the "Method" section) on the 1000-SNP data sets, and six methods (FIM, IG, BEAM, MECPM, SH and LR) on the 10,000-SNP data sets - we do not evaluate MDR for the 10,000-SNP data sets because the high memory occupancy of the MDR software prevents this evaluation. We also evaluated six methods (MDR, FIM, BEAM, MECPM, SH and LR) in Step 3 - we do not evaluate IG and LRIT, because, by design, they only output multi-locus interaction candidates, and thus are inappropriate to be assessed in Step 3's main effect evaluation. Specifically, IG and LRIT will necessarily have 0 true positives, no matter how well they detect interactions involving the main-effect-only SNPs, since in Step 3 only "singlet" main effects are considered to be true positives. MDR, BEAM, SH and MECPM were all implemented using the authors' freely available software. LR, LRIT, FIM and IG were implemented using C++, with the software freely available. The eight methods were tested on the same platform: OS: Windows, CPU: 3G, RAM: 2G. The parameters used by the respective methods follow their default settings wherever possible. We only modified one parameter when testing MDR: we used its heuristic search (1 hour execution time limit) instead of exhaustive search when testing MDR on the 1000-SNP data sets in step 2, because exhaustive search of MDR required huge memory and quite impractically high computational cost - when implementing MDR with exhaustive search, our machine crashed from running out memory; moreover, the *estimated* exhaustive-search MDR execution time for a 1000-SNP, 2000-sample data set is 1.4 × 10^{6} seconds (roughly 15 years) on our platform. Here we compare the eight peer methods along several performance fronts. The results are then further evaluated and summarized in the "Discussion" section.

#### Accuracy of P-value assessment in step 1

*top-ranking*interaction. Thus, in practice, MDR does not in fact use a P-value to practically set an interaction detection threshold.). The average family-wise type I error rates at different significance thresholds were calculated. Since each interaction order has a different Bonferroni penalty, we separately list the results for 1st, 2nd, and 3rd orders, shown in Table 1. BEAM, SH and FIM all have accurate family-wise type I error rates at 1st order, but give conservative results (empirical family-wise type I error rate is less than expected) at 2nd and 3rd order. BEAM is the most conservative and FIM the least. Thus, the P-values generated by these methods are conservative, and not to the same degree. Thus the estimation of power (at the targeted type I error rate value) is likewise both conservative and not truly comparable across the methods. There are multiple causes for this conservativeness, which we subsequently discuss.

The average family-wise type I error rates (step 1) for BEAM, SH and FIM under the significance threshold of 0.1 (after Bonferroni correction). More results can be found in the Additional file 1.

family-wise type I error rate | BEAM | SH | FIM |
---|---|---|---|

1st order | 0.094 | 0.084 | 0.097 |

2nd order | 0 | 0.026 | 0.032 |

3rd order | 0 | 0.002 | 0.006 |

#### Power (definition 1) and ROC curve in step 2

*definition 1*) for each interaction model and also for the entire 15-SNP ground-truth set. Figure 4 and 5 show some of our results for 1000 SNPs and 10,000 SNPs in each data set, respectively. Many more results, under different parameter configurations, are given in the Additional file 1.

For the 1000-SNP case (Figure 4), although the methods can detect some SNPs with strong interacting effects (Figure 4(c), model 2), most of the methods (MDR, BEAM, IG, FIM, SH, and LR) miss many other ground-truth interacting SNPs at a low false positive SNP count (i.e., for small K) (Figure 4(b), (d), (e) and 4(f)); further increases in power are modest and are only attained by accepting many more false positive SNPs. Comparatively, MECPM performs quite well on most interaction models (including the difficult five-way (Figure 4(f)) and the three-way interactions (Figure 4(d) and 4(e)), except for model 1 (Figure 4(b)). Only a partial curve is shown for MECPM because MECPM uses the BIC criterion to choose its model order (and, thus, the number of interactions) [40]. Few true SNPs are added as *K* is increased beyond the BIC stopping point -- MECPM has high specificity at the BIC stopping point [40] (MECPM specificity = 0.99 for the whole ground truth SNP set at the BIC stopping point). Accordingly, MECPM execution was terminated shortly after the BIC stopping point. From Figure 4(a), MECPM is overall the best-performing method, with SH second, BEAM third, FIM fourth, the baseline LR fifth, LRIT sixth, IG seventh and MDR eighth. Individual methods perform more favorably for certain models, *e.g*. IG performs well for a 3-way model (Figure 4(e)). Also, all methods tend to detect more interacting SNPs with strong main effects than those with weak main effects (power of all the methods on models 2 and 3 is generally higher than on models 1, 4, and 5). We give some explanation for these results in the "Discussion" section.

For the 10,000-SNP case (Figure 5), we have similar observations as in the 1000-SNP case, except that the general performance of all methods is degraded. It is worth noting that all the methods perform comparably to their 1000-SNP detection power for model 2 (Figure 5(c)), and MECPM also performs comparably to its 1000-SNP detection power for models 3 and 4 (Figure 5(d) and 5(e)). MECPM is the overall best-performing method, with SH second, BEAM third, LR fourth, LRIT fifth, FIM sixth and IG seventh.

#### Impact of penetrance, MAF, and LD on power (definition 1)

#### Reproducibility of power (definition 1)

We measured the reproducibility by the standard deviation of power across the 100 replication data sets. These results are given in the Additional file 1.

#### Power (definition 1) to detect interacting SNPs for a fixed significance threshold

Although the statistical significance level is unreliable for measuring performance of the methods (as illustrated in Table 1), we want to give readers an empirical sense of how the methods perform when using the statistical significance level to select candidate SNPs in the step 2 experiment. These results, given in the Additional file 1, show that using the same significance threshold, the methods detect very different numbers of both true positive and false positive SNPs. Moreover, considering the balance of true positives and false positives achieved by each of the methods, none of them performs strongly.

#### Power to detect entire interactions (definition 2)

*definition 2*, we did experiments to evaluate all the methods on the 1000-SNP data sets of Step 2. Considering the high computational complexity and the applicability of the methods, we compare the power of IG, LRIT, FIM, SH and MDR on 2-way interactions, the power of FIM, SH, and MDR on 3-way interactions, and the power of MDR on 5-way interactions. Figure 7 shows the results. Due to the limited number of

*total*interactions output by BEAM and MECPM, we do not evaluate BEAM here, and list the power of MECPM only at its stopping point: model 1 - 0, model 2 - 0.96, model 3 - 0.94, model 4 - 0, model 5 - 0.46.

We can observe that all the methods have poor performance for models 1 and 4. For models 3 and 5, all the methods fare poorly except for MECPM. For model 2, IG, LRIT and FIM have very good performance (power = 1); MECPM also performs well (power = 0.96); while the other methods still perform poorly.

#### Power to detect at least 1 SNPin an interaction - partial interaction detection (definition 3)

*definition 3*, we evaluated SH, BEAM, IG, FIM, MDR, LRIT and MECPM. The major results are shown in Figure 8. Due to the limited number of

*total*interactions output by MECPM at its stopping criteria, we give a text description, instead of drawing a curve, to show the power at its stopping point: model 1 - 0.17, model 2 - 1, model 3 - 0.98, model 4 - 0.97, model 5 - 0.46. From Figure 8, BEAM, SH, FIM, LRIT and MECPM obtain good results for models 2, 3, 4, 5. We believe that these good results are partly due to the relatively strong main effects of SNPs involved in these interaction models. Note that there is a substantial increase in power compared to Figure 7. Also, by comparing with the results for power

*definition 1*(Figure 4), we can see that there is largely increased power for most models, indicating most interaction models can be partly detected by the methods.

#### Power to detect individual SNP main effects (definition 4)

Also, we observe similar power for SNPs participating in interactions with symmetric penetrance tables and the same MAFs. For example, all the SNPs in model 1 and model 5 have similar power; likewise for SNPs *B* and *C* in models 3 and 4. This observation is reasonable since these SNPs not only have the same main effects, but also have the same interaction effects.

For SNPs participating in interactions with a symmetric penetrance table but different MAFs, an interesting (and perhaps unexpected) finding is that for model 2, the power to detect SNP *A* (MAF = 0.2), is *greater than* the power to detect SNP *B*, which has a larger MAF (MAF = 0.3). We give theoretical justification for this result in section 1 of the Additional file 1.

#### Performance for step 3, the main-effect-only case

*definition 4*to evaluate performance of the methods on the main-effect-only data sets in Step 3. We did not include the IG and LRIT method in this Step because IG and LRIT only detect multilocus interactions, not single (main effect) SNPs; thus, for Step 3, involving only main effects, detected interactions, even ones involving the main effect SNPs, are necessarily false positive interactions. Figure 10 shows the power curves, from which we observe that, except for MDR, most methods (FIM, BEAM, SH, MECPM, LR) achieve similar, good power at the beginning, with SH becoming a bit better as

*K*increases.

*only*main effects. Here we evaluated the 3 methods that give P-value assessments, looking at the number of false positive interactions detected under the P-value of 0.1 after Bonferroni correction. Table 2 lists the results, from which we can see that BEAM and SH are quite good at inhibiting false positive interactions caused by marginal effects, but FIM produces many false positive interactions.

The average number of false positive interactions (step 3) for BEAM, SH and FIM under the significance threshold of 0

number of false positives | BEAM | SH | FIM |
---|---|---|---|

2nd order | 0 | 0 | 2.21 |

3rd order | 0 | 0 | 64.19 |

#### Computational complexity and memory occupancy

## Discussion

### General Summary of the Study and Its Results

We report a comparison of eight representative methods, multifactor dimensionality reduction (MDR), full interaction model (FIM), information gain (IG), Bayesian epistasis association mapping (BEAM), SNP harvester (SH), maximum entropy conditional probability modeling (MECPM), logistic regression with an interaction term (LRIM), and logistic regression (LR). The first seven were specifically designed to detect interactions among SNPs, and the last is a popular main-effect testing method serving as a baseline for performance evaluation. The selected methods were compared on a large number of simulated data sets, each, consistent with complex disease models, embedded with *multiple* sets of interacting SNPs, under different interaction models. The assessment criteria included several relevant detection power measures, family-wise type I error rate, and computational complexity. The principal experimental results are as follows: i) while some SNPs in interactions with strong effects are successfully detected, most of the methods miss many interacting SNPs at an acceptable rate of false positives; in this study, the best-performing method was MECPM; ii) the statistical significance assessment criteria, used by some of these methods to control the type I error rate, are quite conservative, which further limits their power and makes it difficult to fairly compare them; iii) the power varies for different models as a function of penetrance, minor allele frequency, linkage disequilibrium and marginal effects; iv) analytical relationships between power and these factors are derived, which support and help explain the experimental results; v) for these methods the magnitude of the main effects plays an important role in whether an interacting SNP is detected; vi) most methods can detect some ground-truth SNPs, but fare modestly at detecting the whole set of interacting SNPs.

### Based on the simulation data sets used in this study, which include multiple interaction models present in each data set in Step 2, most of the methods miss some interacting SNPs, leading to only moderate power at low false positive SNP counts (Figures 4, 5)

Compared to the promising powers achieved for the simulation studies reported in the methods' respective papers, the degraded performance seen in this comparative study for most methods is attributed to the more difficult yet likely more realistic simulation data that we used. The methods (excepting LR and MECPM) were previously reported as powerful on simulation data sets including only a single, strong ground-truth interaction, but our study included 5 interactions present in each data set to simulate multiple genetic causes for complex diseases. The disease risk is thus effectively divided among the 5 interaction models, giving each a weaker (less easily detected) effect.

### Main effects play an important role in whether a ground-truth SNP is detected at low false positive SNP counts

Another notable finding is that the main effects of the interacting SNPs affect their likelihood of being detected at low false positive SNP counts by most methods. For interaction models with very weak marginal effects (models 1 and 5), all the methods have low power (see Figure 4(b) and 4(f)). Although some methods (e.g. SH) emphasize the detection of interactions with weak marginal effects, their results on these models are very modest. Heuristic search strategies used by the methods count on at least one SNP in the interaction having a relatively strong effect; this explains why model 1, without strong main effects, is difficult to detect. Moreover, the huge search space for 5-way interactions makes it easy for heuristic search strategies to miss model 5.

### For the same interaction model, different levels of power are achieved by the eight methods

For each interaction model, the power varies across methods because of the quite different detection principles applied by the methods. For example, IG and LRIT, which are based on pairwise SNP statistics, can detect 2-way interaction effects well (see models 2 and 4, where model 4 can be considered as two overlapped 2-way interactions), but IG and LRIT gets poorer results for higher-order models. For the difficult 5-way interaction, only MECPM gave promising results.

### Power on the whole ground-truth SNP set - MECPM performs the best, while MDR performs the worst

From Figure 4(a), MECPM achieves the best performance; BEAM, SH, FIM, LR, LRIT and IG have similar and moderate performance; MDR performs the worst, among the eight methods we tested. From Figure 6, SH outperforms BEAM and FIM for weaker effects (i.e., for discounted penetrance values and MAF). Here we briefly discuss how these performance differences are a product of the different methodologies employed.

Power may be degraded by an insufficiently sensitive ranking criterion, by the heuristic search strategy used, or by a suboptimal output design of a method. The high computational complexity of MDR necessitates using its heuristic search option to keep the running time/memory usage in a reasonable range. This heuristic search forces a significantly reduced search space, and hence the performance of MDR is expected to be degraded.

The ranking criterion of IG detects pure interaction effects (see equation (4) and the definition of mutual information). However, what really affects disease risk is a combination of both pure interaction effects and main effects. Additionally, IG is only explicitly designed to detect 2-way interactions, and thus may have difficulty detecting higher order ones.

Comparatively, MECPM, BEAM, FIM and SH have less critical limitations, with these mainly in the sensitivity of their ranking criteria and their use of heuristic search -- e.g., the difficulty for heuristic search to pick up interactions with weak marginal effects and high-order interactions due to the large search space (Consider a contingency table with 3^{5} = 243 cells for a 5-way interaction.).

### The performance of the methods is sensitive to changes in penetrance value, MAF, and LD

From Figure 6, the seven methods all have clearly decreased power when we reduce penetrance values and the MAF, or replace ground-truth SNPs by surrogates in LD with them. Among the methods, SH is the most robust while IG is the most sensitive to these factors. Besides our empirical results, a theoretical analysis of how power changes with penetrance or MAF is given in the Additional file 1. The analytical results, which are consistent with (and thus support and explain) our experimental results are as follows: 1) increasing the penetrance of an interaction model results in both a stronger (more easily detected) joint interaction effect and in stronger marginal effects of the participating SNPs; 2) increasing the frequency of a disease-related genotype results in a stronger joint effect, under certain conditions; 3) the impact of genotype frequency on main effects is more complicated -- when the marginal frequency, *a*, of a disease-related genotype is small, the strengths of the marginal effects increase when *a* increases, and when *a* is large, the strengths of the marginal effects *decrease* as *a* increases.

### Most methods can partially but not exactly detect the interactions

The results for power *definition 2* (see Figure 7) are quite different from those for power *definition 1* (see Figure 4), indicating that most methods detect the interacting ground truth SNPs as singlets or subsets of the ground truth interactions. There are multiple reasons for this, in some cases method-specific. For example, the large degrees of freedom of FIM render a high false positive rate, making ground-truth interactions easily buried amongst many false positives; due to the use of heuristic search strategies, the methods may not even *evaluate* the ground-truth interactions as candidates; also, for some methods, e.g. FIM, successful detection of an interaction relies on *first* detecting main effects for (at least some) SNPs involved in the interaction, thus this type of heuristic search strategy will miss ground-truth interactions that possess only weak main effects; moreover, SH *excludes* SNPs with strong main effects from higher-order search, so SH in particular will miss interactions that possess *strong* main effects (see Figure 7(b)).

### The P-value assessments of BEAM, SH and FIM are variable across method and all are overly conservative

From the subsection "*Power for a fixed significance threshold*" and results given in the Additional file 1, we observe that for the same significance threshold, BEAM, SH and FIM have quite different power and false positive SNP counts. Also, in the subsection "*Accuracy of P-value assessment in step 1*", we showed that their P-value assessments are conservative for 2nd and 3rd order interactions. From further experiments, we conclude that this phenomenon originates from three factors: the heuristic search strategies, dependencies between SNP combinations, and the summary statistics used by the methods.

For BEAM, SH, and FIM, the heuristic search strategies evaluate fewer SNP combination candidates than the number actually penalized in the Bonferroni correction. Moreover, SH and BEAM exclude SNPs with strong marginal effects from high-order interactions, which further decreases the number of searched SNP combinations. So the Bonferroni-corrected P-value is smaller than it should be. Also, some SNP combinations have dependencies with others, either because they share a common SNP subset and/or because SNPs in different subsets are in LD. Such dependencies make the Bonferroni correction inherently conservative.

Besides heuristic search and dependencies, the conservativeness also derives from the summary statistics themselves. The authors of BEAM evaluated the B statistic's conservativeness with exhaustive search. In the Additional file 1, we likewise evaluate conservativeness of the *χ*^{2} statistics applied by SH and FIM. We considered the case where there is neither multiple testing nor heuristic search. The *χ*^{2} statistics turn out to be conservative, becoming more so as the significance threshold is decreased (see Tables 1, 2 in the Additional file 1). Theoretically, such conservativeness may come from the discreteness of the SNP data. Since the *χ*^{2} statistics in SH and FIM are calculated from the discrete-valued SNP data, the *χ*^{2} statistics are also discrete. At the tail part of the *χ*^{2} distribution, two consecutive discrete *χ*^{2} values may correspond to very different significance levels. For example, let the P-values of consecutive *χ*^{2} values be *p*_{1}, *p*_{2} (*p*_{1} >> *p*_{2}); when the significance threshold is *p*_{0} and *p*_{1} > *p*_{0} >*p*_{2}, the type I error rate actually corresponds to *p*_{2}, which is much less than *p*_{0}, making the results quite conservative.

### Limitations of the Current Study and Future Work

There are a number of possible extensions of this simulation study that we intend to consider in our future work. First, our current simulation software only handles categorical traits and categorical (ternary-valued, SNP) covariates. Environmental covariates and admixture-adjusting variables could be either quantitative or ordinal-valued. Likewise, traits (phenotype) could be quantitative or ordinal. There are natural ways of extending our current simulation approach to allow for these more general covariate and trait types, which we will consider in future work. Second, we have not investigated missing SNP-values and their effect on detection power. Third, while we have chosen five plausible penetrance function models, another possibility would be to use "data-driven" penetrance functions, *i.e*. penetrance functions estimated based on real GWAS data sets with known ground-truth and known (*i.e*., previously detected) interactions.

## Conclusions

The methods explored in this study are useful tools in the exploration of potential interacting loci. Each of the methods studied here has its strengths and weaknesses. Our comparative examination of these methods suggests that continued research into methods that test for interacting loci is necessary to expand the tools available to researchers and to achieve improved power for detecting complex interactions, along with accurate assessment of statistical significance.

## Methods

### Methods Tested in the Comparison Study

*χ*

^{2}or

*B*statistics [32, 39]; BEAM uses Bayesian inference or B statistics; FIM, LRIT and LR are based on the logistic regression model; IG ranks SNPs by mutual information; MDR selects SNPs via prediction error; MECPM uses BIC to rank interactions and to assess statistical significance.

Properties of methods tested in this paper.

Name | Detection Principle | Heuristic search | Asymptotic null distribution | Free-accessible software |
---|---|---|---|---|

MDR | Prediction accuracy | Stochastic | No | |

FIM | Logistic regression | Deterministic | Yes | N/A |

IG | Mutual Info. | N/A | No | N/A |

BEAM | Bayesian model | Stochastic | Yes | |

MECPM | BIC | Deterministic | No | |

SH | χ | Deterministic | Yes | |

LRIT | Logistic regression | N/A | Yes | N/A |

LR | Logistic regression | N/A | Yes | N/A |

A brief summary of these eight methods follows.

#### (1) Multifactor dimensionality reduction (MDR) [33]

For a set of SNPs, MDR labels a genotype as "high-risk" if the ratio between the number of cases and the number of controls exceeds some threshold (e.g., 1.0). A binary variable is thus formed, pooling high-risk genotypes into one group and low-risk ones into another. If the subject has a high-risk genotype it is predicted as a case; otherwise as a control. The prediction error of each model is estimated by 10-fold cross validation and serves as the measure of association between the set of SNPs and the disease.

#### (2) Full Interaction Model (FIM) [41]

^{ d }-1 binary variables

*x*

_{ j }

*, j*= 1,2,..., 3

^{ d }-1 are introduced for a subset of

*d*SNPs and a logistic regression model with 3

^{ d }parameters is estimated from the data.

*x*

_{ j }(

*i*) corresponds to the

*jth*genotype combination (or interaction term) of the SNP subset on the

*ith*subject.

*x*

_{ j }(

*i*) = 1 if the

*jth*genotype combination is present for the

*ith*subject, and 0 otherwise. For the row vector , let

*π*(

**x**(

*i*)) be the disease risk. The logistic regression is parameterized as

where
are estimated via maximum likelihood estimation. A likelihood-ratio test is applied to calculate the significance of this SNP subset via an asymptotic *χ*^{2} distribution.

#### (3) Information Gain (IG) [34]

where the mutual information *I*(*A*;*B*) is a non-negative measure of the reduction in uncertainty about the value of (SNP locus) random variable *A*, given knowledge of random variable *B*[61] Equivalently, it is a measure of the statistical dependence between *A* and *B*. The conditional mutual information *I*(*A*;*B |C*) likewise gives a measure of the statistical dependence between *A* and *B* given that the phenotype random variable, *C*, is known. The magnitude of IG thus indicates the increased statistical dependence between *A* and *B* given knowledge of *C, i.e*. the strength of an interaction between loci *A* and *B*.

#### (4) Bayesian Epistasis Association Mapping (BEAM) [32]

*N*samples (

*N*

_{ d }cases and

*N*

_{ u }controls) are genotyped at

*L*SNPs. BEAM partitions the

*L*SNPs into 3 groups: markers with no association with disease, markers with only main effects, and markers with interaction effects. Let the genotypes on cases be

*D*= (

*d*

_{1},...,

*d*

_{ L }) with representing genotype vector of the

*j*th SNP at all the cases. According to the abovementioned partitioning,

*D*can be divided into three subsets,

*D*

_{0},

*D*

_{1}, and

*D*

_{2}, where

*D*

_{0}is the subset consisting of SNPs (SNP genotype vectors) with no association,

*D*

_{1}is the subset consisting of SNPs with only main effects, and

*D*

_{2}is the subset consisting of SNPs with interaction effects. Likewise, let the genotypes on controls be

*U*= (

*u*

_{1},...,

*u*

_{ L }

*)*with representing genotypes of the

*j*th SNP at the controls. Let

**I**= [

*I*

_{1},

*I*

_{2},...,

*I*

_{L}] be the membership of SNPs within each group, e.g.

*I*

_{ j }= 0 means that the

*jth*SNP has a main effect,

*I*

_{ j }= 1 means that the

*jth*SNP has only main effects,

*I*

_{ j }= 2 means that the

*jth*SNP has interaction effects. Let

*P*() be the probability symbol. Following some assumptions [32], the posterior distribution of

**I**given

*D*and

*U*is inferred by:

Based on equation (5), BEAM draws **I** using the Metropolis-Hastings algorithm. The output is the posterior probability of main-effect markers and interactions associated with the disease. A "*B*" statistic is also applied to measure statistical significance of SNPs and interactions.

#### (5) SNP Harvester (SH) [39]

This method aims to detect interactions with weak marginal effects. It includes the following steps:

5a. Remove SNPs with significant main effects;

5b. For a fixed *M*, run the "PathSeeker" heuristic search to identify *M*-way SNP interactions. First, randomly select *M* SNPs to form a *M*-way set A = {*x*_{1}, *x*_{2},..., *x*_{
M
} }. Second, swap one of the remaining SNPs with each member of **A**, to see whether a statistical score *s*(**A**) (e.g. χ^{2}statistic, *B* statistic) increases. Then iteratively repeat this second step until convergence; record *s*(**A**) if statistically significant. Then go back to the first step, with the optimal **A** removed as a candidate for the next run.

5c. Use L2-norm penalized logistic regression [37] as a post processing step to further select interactions from those identified in 5b.

Although SH *removes* SNPs with strong main effects, for purpose of fair comparison, we still give it credit for identifying these main-effect SNPs in calculating its power.

#### (6) Maximum entropy conditional probability modeling (MECPM) [40]

MECPM builds the phenotype posterior under a maximum entropy principle, encodes constraints into the model that correspond 1-to-1 to interactions, flexibly allows dominant or recessive coding for each locus in a candidate interaction, searches interactions via a greedy interaction growing search strategy that evaluates candidates up to fifth order, and uses the Bayesian information criterion (BIC) as the model selection strategy.

#### (7) Logistic regression (LR) [35]

*x*(

*i*) correspond to the genotype of a SNP for the

*ith*subject.

*x*(

*i*) = 0 denotes homozygous major alleles;

*x*(

*i*) = 1 denotes heterozygous genotypes; and

*x*(

*i*) = 2 denotes homozygous minor alleles. Let

*π*(

*x*(

*i*)) be the disease risk. The logistic regression is parameterized as:

, where *β*_{0} and *β*_{1} are the regression coefficients, learned via maximum likelihood. By a likelihood ratio test, logistic regression evaluates statistical significance for each SNP.

#### (8) Logistic regression with interaction term (LRIT) [35]

*x*

_{ m }(

*i*) and

*x*

_{ n }(

*i*) correspond to genotypes of the

*mth*SNP and

*nth*SNPs for the

*ith*subject, respectively.

*x*

_{ m }(

*i*) = 0 or

*x*

_{ n }(

*i*) = 0 denotes homozygous major alleles;

*x*

_{ m }(

*i*) = 1 or

*x*

_{ n }(

*i*) = 1 denotes heterozygous genotypes; and

*x*

_{ m }(

*i*) = 2 or

*x*

_{ n }(

*i*) = 2 denotes homozygous minor alleles. Let

*π*(

*x*

_{ m }(

*i*),

*x*

_{ n }(

*i*)) be the disease risk. The logistic regression is parameterized as:

, where *β*_{0}, *β*_{1}, *β*_{2}, *β*_{3} are the regression coefficients, learned via maximum likelihood. By a likelihood ratio test, logistic regression evaluates the statistical significance for this pair of SNPs (the statistical significance reflects the joint effects of the two individual terms and the multiplicative term).

## Declarations

### Acknowledgements

This work was supported in part by the National Institutes of Health (HL090567 to D.M.H. and GM085665 to Y.W.).

## Authors’ Affiliations

## References

- Brookes A: Review: the essence of SNPs. Gene. 1999, 234: 177-186. 10.1016/S0378-1119(99)00219-X.View ArticlePubMedGoogle Scholar
- Couzin J, Kaiser J: Genome-wide association. Closing the net on common disease genes. Science. 2007, 316: 820-2. 10.1126/science.316.5826.820.View ArticlePubMedGoogle Scholar
- Hirschhorn J: Genome-wide association studies for common diseases and complex traits. Nature reviews Genetics. 2005, 6: 95-108.View ArticlePubMedGoogle Scholar
- Donnelly P: Progress and challenges in genome-wide association studies in humans. Nature. 2008, 456: 728-31. 10.1038/nature07631.View ArticlePubMedGoogle Scholar
- Manolio TA, et al: Finding the missing heritability of complex diseases. Nature. 2009, 461: 747-53. 10.1038/nature08494.View ArticlePubMedPubMed CentralGoogle Scholar
- T. W. T. C. C. Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447: 661-78. 10.1038/nature05911.View ArticleGoogle Scholar
- Wang WY, et al: Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet. 2005, 6: 109-18. 10.1038/nrg1522.View ArticlePubMedGoogle Scholar
- Hardy J, Singleton A: Genomewide association studies and human disease. N Engl J Med. 2009, 360: 1759-68. 10.1056/NEJMra0808700.View ArticlePubMedPubMed CentralGoogle Scholar
- Ku CS, et al: The pursuit of genome-wide association studies: where are we now?. Journal of Human Genetics. 2010, 55: 195-206. 10.1038/jhg.2010.19.View ArticlePubMedGoogle Scholar
- Mohlke KL, et al: Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Hum Mol Genet. 2008, 17: R102-8. 10.1093/hmg/ddn275.View ArticlePubMedPubMed CentralGoogle Scholar
- Kathiresan S, et al: Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008, 358: 1240-9. 10.1056/NEJMoa0706728.View ArticlePubMedGoogle Scholar
- Samani NJ, et al: Genomewide association analysis of coronary artery disease. N Engl J Med. 2007, 357: 443-53. 10.1056/NEJMoa072366.View ArticlePubMedPubMed CentralGoogle Scholar
- McPherson R, et al: A common allele on chromosome 9 associated with coronary heart disease. Science. 2007, 316: 1488-91. 10.1126/science.1142447.View ArticlePubMedPubMed CentralGoogle Scholar
- Tsai FJ, et al: A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2007, 6: e1000847-View ArticleGoogle Scholar
- Scott LJ, et al: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007, 316: 1341-5. 10.1126/science.1142382.View ArticlePubMedPubMed CentralGoogle Scholar
- Paterson AD, et al: A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose. Diabetes. 2010, 59: 539-49. 10.2337/db09-0653.View ArticlePubMedGoogle Scholar
- Saxena R, et al: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007, 316: 1331-6.View ArticlePubMedGoogle Scholar
- Freedman BI, et al: Differential effects of MYH9 and APOL1 risk variants on FRMD3 association with diabetic ESRD in African Americans. PLoS Genet. 2011,Google Scholar
- Harley JB, et al: Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008, 40: 204-10. 10.1038/ng.81.View ArticlePubMedPubMed CentralGoogle Scholar
- Harley IT, et al: Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet. 2009, 10: 285-90. 10.1038/nrg2571.View ArticlePubMedPubMed CentralGoogle Scholar
- Crow MK: Collaboration, genetic associations, and lupus erythematosus. N Engl J Med. 2008, 358: 956-61. 10.1056/NEJMe0800096.View ArticlePubMedGoogle Scholar
- Lettre G, Rioux JD: Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet. 2008, 17: R116-21. 10.1093/hmg/ddn246.View ArticlePubMedPubMed CentralGoogle Scholar
- Hussman JP, et al: A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism. 2011, 2: 1-10.1186/2040-2392-2-1.View ArticlePubMedPubMed CentralGoogle Scholar
- Easton DF, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007, 447: 1087-93. 10.1038/nature05887.View ArticlePubMed CentralGoogle Scholar
- Easton DF, Eeles RA: Genome-wide association studies in cancer. Human Molecular Genetics. 2008, 17: R109-R115. 10.1093/hmg/ddn287.View ArticlePubMedGoogle Scholar
- Hunter DJ, et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007, 39: 870-4. 10.1038/ng2075.View ArticlePubMedPubMed CentralGoogle Scholar
- Amundadottir L, et al: Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009, 41: 986-90. 10.1038/ng.429.View ArticlePubMedPubMed CentralGoogle Scholar
- Maher B: Personal genomes: The case of the missing heritability. Nature. 2008, 456: 18-21.View ArticlePubMedGoogle Scholar
- Cordell H: Detecting gene-gene interactions that underlie human diseases. Nature reviews Genetics. 2009, 10: 392-404.View ArticlePubMedPubMed CentralGoogle Scholar
- Moore JH, et al: Bioinformatics challenges for genome-wide association studies. Bioinformatics. 2010, 26: 445-55. 10.1093/bioinformatics/btp713.View ArticlePubMedPubMed CentralGoogle Scholar
- Musani SK, et al: Detection of gene × gene interactions in genome-wide association studies of human population data. Hum Hered. 2007, 63: 67-84. 10.1159/000099179.View ArticlePubMedGoogle Scholar
- Zhang Y, Liu JS: Bayesian inference of epistatic interactions in case-control studies. Nat Genet. 2007, 39: 1167-73. 10.1038/ng2110.View ArticlePubMedGoogle Scholar
- Ritchie MD, et al: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001, 69: 138-47. 10.1086/321276.View ArticlePubMedPubMed CentralGoogle Scholar
- Moore JH, et al: A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006, 241: 252-61. 10.1016/j.jtbi.2005.11.036.View ArticlePubMedGoogle Scholar
- Agresti A: Categorical data analysis. 2002, New York: Wiley-Interscience, 2View ArticleGoogle Scholar
- Kooperberg C, Ruczinski I: Identifying interacting SNPs using Monte Carlo logic regression. Genet Epidemiol. 2005, 28: 157-70. 10.1002/gepi.20042.View ArticlePubMedGoogle Scholar
- Park MY, Hastie T: Penalized logistic regression for detecting gene interactions. Biostatistics. 2008, 9: 30-50.View ArticlePubMedGoogle Scholar
- G Yu, et al: Detection of complex interactions of multi-locus SNPs," presented at IEEE Machine Learning for Signal Processing. 2008, Cancun, MexicoGoogle Scholar
- Yang C, et al: SNPHarvester: a filtering-based approach for detecting epistatic interactions in genome-wide association studies. Bioinformatics. 2009, 25: 504-11. 10.1093/bioinformatics/btn652.View ArticlePubMedGoogle Scholar
- Miller DJ, et al: An Algorithm for Learning Maximum Entropy Probability Models of Disease Risk That Efficiently Searches and Sparingly Encodes Multilocus Genomic Interactions. Bioinformatics. 2009, 25: 2478-2485. 10.1093/bioinformatics/btp435.View ArticlePubMedPubMed CentralGoogle Scholar
- Marchini J, et al: Genome-wide strategies for detecting multiple loci that influence complex diseases. Nature Genetics. 2005, 37: 413-417. 10.1038/ng1537.View ArticlePubMedGoogle Scholar
- Schwender H, Ickstadt K: Identification of SNP interactions using logic regression. Biostatistics. 2008, 9: 187-198.View ArticlePubMedGoogle Scholar
- Yang C, et al: Identifying main effects and epistatic interactions from large-scale SNP data via adaptive group Lasso. BMC Bioinformatics. 2010, 11 (Suppl 1): S18-10.1186/1471-2105-11-S1-S18.View ArticlePubMedPubMed CentralGoogle Scholar
- Breiman L: Random forests. Machine Learning. 2001, 45: 5-32. 10.1023/A:1010933404324.View ArticleGoogle Scholar
- Wang X, et al: The meaning of interaction. Human Heredity. 2010, 70: 269-277. 10.1159/000321967.View ArticlePubMedPubMed CentralGoogle Scholar
- W Li, Reich J: A complete enumeration and classification of two-locus disease models. Hum Hered. 2000, 50: 334-49. 10.1159/000022939.View ArticleGoogle Scholar
- Szymczak S, et al: Machine learning in genome-wide association studies. Genet Epidemiol. 2009, 33 (Suppl 1): S51-7.View ArticlePubMedGoogle Scholar
- Van Steen K: Travelling the world of gene-gene interactions. Brief Bioinform. 2011, 1-19.Google Scholar
- Garcia-Magarinos M, et al: Evaluating the ability of tree-based methods and logistic regression for the detection of SNP-SNP interaction. Ann Hum Genet. 2009, 73: 360-9. 10.1111/j.1469-1809.2009.00511.x.View ArticlePubMedGoogle Scholar
- Motsinger-Reif AA, et al: A comparison of analytical methods for genetic association studies. Genet Epidemiol. 2008, 32: 767-78. 10.1002/gepi.20345.View ArticlePubMedGoogle Scholar
- Carlborg O, Haley C: Epistatis: too often neglected in complex trait studies?. Nature Reviews Genetics. 2004, 5: 618-625. 10.1038/nrg1407.View ArticlePubMedGoogle Scholar
- Jakulin A, Bratko I: Testing the Significance of Attribute Interactions," presented at the 21st International Conference on Machine Learning (ICML-2004). 2004, Banff, CanadaGoogle Scholar
- Jung HY, et al: New methods for imputation of missing genotype using linkage disequilibrium and haplotype information. Information Sciences. 2007, 177: 804-814. 10.1016/j.ins.2006.07.017.View ArticleGoogle Scholar
- Chen L, et al: A Ground Truth Based Comparative Study on Detecting Epistatic SNPs. presented at Proc. IEEE Intl Conf. on Bioinformatics & Biomedicine, Washington D.C., USA. 2009Google Scholar
- Hochberg Y, Tamhane AC: Multiple comparison procedures. 1987, New York: WileyView ArticleGoogle Scholar
- Neel J: Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress". Am J Hum Genet. 1962, 14: 353-362.PubMedPubMed CentralGoogle Scholar
- Wolf J, et al: Epistasis and the Evolutionary Process. 2000, New York: Oxford University Press Inc.Google Scholar
- Wright FA, et al: Simulating association studies: a data-based resampling method for candidate regions or whole genome scans. Bioinformatics. 2007, 23: 2581-8. 10.1093/bioinformatics/btm386.View ArticlePubMedGoogle Scholar
- Yuan X, et al: Simulating linkage disequilibrium structures in a human population for SNP association studies. Biochem Genet. 2011, 49: 395-409. 10.1007/s10528-011-9416-x.View ArticlePubMedPubMed CentralGoogle Scholar
- Cordell H: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Human Molecular Genetics. 2002, 11: 2463-2468. 10.1093/hmg/11.20.2463.View ArticlePubMedGoogle Scholar
- Cover TM, Thomas JA: Elements of Information Theory. 1991, New York City: John Wiley & Sons, Inc.View ArticleGoogle Scholar

## Copyright

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.